Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alternative Prostate Treatments Among New Procedures Broached By NICE

This article was originally published in The Gray Sheet

Executive Summary

Transurethral electrovaporization of the prostate (TEVAP) appears to be as efficacious as the current surgical resection "gold standard" in benign prostatic hyperplasia treatment, the UK's National Institute for Clinical Excellence says in an interventional procedures program document released for public comment May 27

You may also be interested in...



NICE Addresses Balloon Kyphoplasty, Deep-Brain Stimulation Procedures

Deep-brain stimulation for Parkinson's disease is grated initial endorsement from the UK's National Institute for Clinical Excellence in a consultation program launched June 24

NICE Addresses Balloon Kyphoplasty, Deep-Brain Stimulation Procedures

Deep-brain stimulation for Parkinson's disease is grated initial endorsement from the UK's National Institute for Clinical Excellence in a consultation program launched June 24

NICE Opens Consultation On AAA Stenting, Other UK Interventional Procedures

New abdominal aortic aneurysm endovascular stent grafts may increase the number of patients who undergo the procedure, according to NICE

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel